StonvexLoading…
StonvexStonvexStonvexCore line items from LH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $13.95B | $13.01B | $12.16B | $11.86B |
Operating Income | $1.38B | $1.09B | $725.60M | $1.44B |
Net Income | $876.50M | $746.00M | $418.00M | $1.28B |
EPS (Diluted) | $10.46 | $8.84 | $4.77 | $13.97 |
Total Assets | $18.39B | $18.38B | $16.73B | $20.16B |
Total Liabilities | $9.76B | $10.31B | $8.83B | $10.04B |
Cash & Equivalents | $532.30M | $1.52B | $536.80M | $320.60M |
Free Cash Flow OCF − CapEx | $1.21B | $1.10B | $874.10M | $1.53B |
Shares Outstanding | 82.20M | 83.40M | 83.90M | 88.20M |